Wedge Capital Management’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-79,103
| Closed | -$432K | – | 450 |
|
|
2021
Q1 | $432K | Sell |
79,103
-63,177
| -44% | -$345K | 0.01% | 382 |
|
|
2020
Q4 | $610K | Hold |
142,280
| – | – | 0.01% | 380 |
|
|
2020
Q3 | $428K | Hold |
142,280
| – | – | 0.01% | 396 |
|
|
2020
Q2 | $441K | Sell |
142,280
-9,512
| -6% | -$29.5K | 0.01% | 367 |
|
|
2020
Q1 | $335K | Buy |
151,792
+49,973
| +49% | +$110K | 0.01% | 386 |
|
|
2019
Q4 | $311K | Sell |
101,819
-246,532
| -71% | -$753K | ﹤0.01% | 469 |
|
|
2019
Q3 | $1.07M | Buy |
+348,351
| New | +$1.07M | 0.01% | 320 |
|
|
2019
Q2 | – | Sell |
-236,095
| Closed | -$1.02M | – | 617 |
|
|
2019
Q1 | $1.02M | Buy |
236,095
+92,152
| +64% | +$397K | 0.01% | 359 |
|
|
2018
Q4 | $458K | Hold |
143,943
| – | – | 0.01% | 444 |
|
|
2018
Q3 | $756K | Sell |
143,943
-25,011
| -15% | -$131K | 0.01% | 411 |
|
|
2018
Q2 | $904K | Buy |
168,954
+92,045
| +120% | +$492K | 0.01% | 371 |
|
|
2018
Q1 | $385K | Buy |
+76,909
| New | +$385K | ﹤0.01% | 488 |
|
|
2015
Q4 | – | Sell |
-123,800
| Closed | -$468K | – | 595 |
|
|
2015
Q3 | $468K | Hold |
123,800
| – | – | ﹤0.01% | 455 |
|
|
2015
Q2 | $706K | Sell |
123,800
-700
| -0.6% | -$3.99K | 0.01% | 375 |
|
|
2015
Q1 | $725K | Sell |
124,500
-12,200
| -9% | -$71K | 0.01% | 360 |
|
|
2014
Q4 | $775K | Sell |
136,700
-5,000
| -4% | -$28.3K | 0.01% | 361 |
|
|
2014
Q3 | $580K | Buy |
+141,700
| New | +$580K | 0.01% | 426 |
|